In a landscape dominated by fluctuating box office success, IMAX is poised for an extraordinary year in 2025, with projected revenues reaching a staggering $1.2 billion. This optimistic outlook was shared by the company’s CEO, Rich Gelfond, during an interview with CNBC’s “Squawk on the Street.” The anticipated financial windfall stems from a promising lineup
Business
The long-standing shortage of Novo Nordisk’s semaglutide, encapsulated in its widely recognized injectable medications, Wegovy and Ozempic, has finally come to a resolution. Announced by the U.S. Food and Drug Administration (FDA), this development not only addresses the pressing needs of patients grappling with weight loss and diabetes treatment but also significantly impacts the landscape
After decades of strict grooming standards, the New York Yankees have made a significant change to their iconic policies regarding player appearances. For the first time in nearly 50 years, players are now permitted to grow “well-groomed beards.” This decision, announced by team owner Hal Steinbrenner, marks a pivotal moment in the franchise’s history, reflecting
In recent times, UnitedHealthcare, a powerhouse in the American health insurance landscape, is once again finding itself in a storm of scrutiny and challenges. The company’s parent entity, UnitedHealth Group, is facing multiple crises including governmental investigations, potential staff reductions, and high-profile disputes. These developments follow a particularly tumultuous year marked by internal upheaval, cyber
Bluebird Bio, once a shining star in the biotech sector known for its innovative gene therapies, has recently announced a sale to private equity firms Carlyle and SK Capital for approximately $30 million. This sale highlights the steep decline from a company that was once valued at nearly $9 billion, ushering in a sobering reality
Rivian Automotive recently concluded its fourth-quarter earnings report, showcasing a blend of commendable achievements coupled with cautionary notes about the future. While Rivian managed to exceed Wall Street’s expectations regarding earnings, achieving its first gross profit of $170 million in the last quarter of 2023, the electric vehicle (EV) manufacturer faces a rather tumultuous road
Once a dominant player in the fast fashion landscape, Forever 21 now finds itself at a crossroads, grappling with the looming threat of a second bankruptcy. The retailer, popular for its trendy clothing at affordable prices, has struggled to maintain its relevance amid fierce competition and financial instability. Recent discussions with liquidators signal the brand’s
Nike, a titan in the athletic apparel market, is making waves with its new collaboration with Kim Kardashian’s Skims, a brand known for its innovative approach to shapewear. Announced recently, this partnership aims to launch an activewear collection under the brand name NikeSKIMS, signaling a shift in strategy as Nike attempts to reclaim market share
In the competitive arena of biotechnology, few companies have experienced the meteoric rise and subsequent challenges of Moderna. The pharmaceutical company has shifted from a dominant player in the COVID-19 vaccine market to a contender looking to reinvent itself in a rapidly evolving landscape. On Friday, Moderna released its fourth-quarter financial results, revealing intriguing insights
Roku, a prominent player in the streaming landscape, saw a tremendous spike in its stock prices, soaring over 10% on a recent Friday. This rally was fueled by solid earnings that surpassed Wall Street’s expectations. During a compelling appearance on CNBC’s “Squawk Box,” CEO Anthony Wood articulated the company’s monumental growth, asserting that more than